Vignesh Chandramouli

Vignesh Chandramouli (HC), a Partner at Oak HC/FT, joined the firm in 2014 and focuses on growth equity and early-stage venture opportunities in Healthcare. Vig currently serves on the Board of Syllable and is a Board Observer at Advise, CareBridge, Mainstreet Health, Notable, OncoHealth, Quartet Health, Unite US, Veda Data, Vesta Healthcare, and VillageMD. Vig is also actively involved with Rialtic and Unified Women's Healthcare. Recent prior investments include Aspire Health (acquired by Anthem), Core Informatics (acquired by Thermo Fisher Scientific), LDI Integrated Pharmacy Services (acquired by Diplomat Pharmacy), Maestro Health (acquired by AXA Group), and Therapy Brands (acquired by KKR). Prior to joining Oak HC/FT, Vig was an Associate with LLR Partners, a middle-market growth equity firm, where he focused on investments in healthcare services companies. Vig received dual Bachelor of Science degrees, magna cum laude, from the University of Pennsylvania’s Wharton School and the School of Engineering and Applied Science.